U.S. and Plaintiff States v. Kroger, No. 3:24-cv-00347 (D. Ore. Feb. 26, 2024)

The United States and nine plaintiff states sued to block the $42 billion proposed merger between the Kroger company and Albertson’s companies, the country’s two largest traditional supermarket chain.  The complaint alleges that the proposed acquisition may substantially lessen competition.  The FTC began an administrative proceeding and the plaintiffs (states and FTC) sought a preliminary…

Read More →

A Bipartisan Coalition of 39 State Attorneys General Urge Congressional Action on Pharmacy Benefit Manager Reform

The National Association of Attorneys General (NAAG) sent a letter to Congressional leaders on behalf of 39 attorneys general who urge congressional leaders to engage in meaningful debate and reform of the current practices of pharmacy benefit managers (PBMs) and to take decisive action to reform the way PBMs conduct business and bring more transparency…

Read More →

State Attorneys General Urge Bridge Funding for the Federal Crime Victims Fund (VOCA)

A bi-partisan coalition of 42 state attorneys general urge the U.S. Senate and House of Representatives to authorize much-needed 2024 bridge funding for the federal Crime Victims Fund (the “VOCA Fund.”) The VOCA Fund supports the provision of essential direct services for crime victims and survivors across the country. According to the U.S. Department of…

Read More →

45 State Attorneys General Join in their Ongoing Efforts to Protect Consumers from Robocalls

A bi-partisan coalition of 45 state attorneys general sent a letter to the Federal Communications Commission (FCC) seeking to safeguard consumers from scam phone calls made by Voice-Over-Internet-Protocol (VoIP) service providers. The attorneys general submitted comments to the FCC on its proposal “to safeguard and secure the open Internet” (NPRM) asking it to clarify that…

Read More →

54 Attorneys General Call on Congress to Study AI and Its Harmful Effects on Children

A bipartisan coalition of 54 state and territory attorneys general urge Congress to study how artificial intelligence (AI) can and is being used to exploit children through child sexual abuse material (CSAM). The attorneys general also asked Congress to propose legislation that would protect children from those abuses. The National Association of Attorneys General (NAAG)…

Read More →

Bipartisan Coalition of Attorneys General Express Support for the G.U.A.R.D. VA Act

A bipartisan coalition of 44 attorneys general express support for the passage of legislative proposals included in Governing Unaccredited Representatives Defrauding (G.U.A.R.D.) Veterans Affairs (VA) Benefits Act. In a letter to congressional leaders, the attorneys general explain that the passing of the bipartisan legislation would hold unaccredited and unregulated actors accountable for targeting and preying…

Read More →

Attorneys General Call on Congress to Pass the Combating Illicit Xylazine Act

A bipartisan coalition of 39 state and territory attorneys general called on leaders of Congress to pass the Combating Illicit Xylazine Act (H.R.1839/S.993). Xylazine is only approved by the U.S. Food and Drug Administration (FDA) as a veterinary medicine and in humans, it is known to depress breathing and heart rate, lower blood pressure, and…

Read More →

Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)

44 plaintiff states filed suit against Teva Pharmaceuticals and 19 of the nation’s largest generic drug manufacturers alleging a broad conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs. The lawsuit was originally Connecticut, was transferred to the MDL court in Pennsylvania.  The lawsuit…

Read More →

Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)

Plaintiff states filed a third lawsuit stemming from the ongoing antitrust investigation into a widespread conspiracy by generic drug manufacturers to artificially inflate and manipulate prices, reduce competition, and unreasonably restrain trade for generic drugs sold across the United States. The complaint focuses on 80 topical generic drugs  and names 26 corporate Defendants and 10…

Read More →

New York et al. v. Meta (originally Facebook Inc.), No. 20-3589 (D.D.C.)

Forty-eight plaintiff states filed a lawsuit against Facebook Inc., alleging that the company harms the public by illegally stifling competition to protect its monopoly power. The states alleged that, over the last decade, the social networking giant illegally acquired competitors in a predatory manner and cut services to smaller firms that threatened its power, depriving…

Read More →